Speaker

Jun Yu (MD, PhD, Professor) is Choh-Ming Li Professor of Medicine and Therapeutics; Assistant Dean, Faculty of Medicine; Director, State Key Laboratory of Digestive Disease; Director, Institute of Digestive Disease; Director, Research Laboratory of Digestive Disease; Faculty of Medicine, The Chinese University of Hong Kong.

Prof. Yu is a Member of Academia Europea; Member of Hong Kong Academy of Science; Member of the Chinese Academy of Medical Sciences; Vice-Chairman of Cancer and Gut Microbiome of Anti-Cancer Association China; Vice-Chairman of China Women Physicians Association (GI session); Council Member of American Gastrointestinal Association (AGA) Microbiome and Microbial Therapy USA (2018-2021) and Council Member of AGA Oncology (2017-2018); Chair professor of Chang Jiang Scholar; Associate Editor of Gut, and Oncogene, Advisory Board of Cancer Cell.

Prof. Yu’s research interests being molecular pathogenesis and biomarkers of gastrointestinal (GI) cancers (gastric, colon and liver); Gut microbiota in GI cancers; Non-alcoholic steatohepatitis (NASH) and its associated liver cancer in relation to the molecular pathogenesis and treatment response. She is clearly a preeminent molecular scientist in gastroenterologist disorders with 605 peer-reviewed publications (e.g. Nature, Cell, Cancer cell, Cell Metab, J Clin Oncol, Cell Research, Gastroenterol, Gut, Nat Microbiol, Mol Cell, J Hepatol). Edited 3 books and 16 book chapters. ISI citation 44338, ISI h-index=105; Google Scholar citation >62,900, h-index 124. She obtained over 50 prestigious awards including The National Natural Science Award (2020 and 2016); Guanghua Engineering Science & Technology Prize China (2022); Top 10 Scientists in Global Gut Microbiome Study (2019); He Liang He Li Science and Technology Progress Award (2018); AGA Council (Oncology) Research Mentor Award USA (2017); WuXi PharmaTech Life Science Award (2017); Croucher Senior Research Fellowship (2016); The National Science and Technology Progress Award (2012). First-class Ministry of Education Higher Education Outstanding Scientific Research Output Awards (2010, 2012, 2014 and 2022).  She is Clarivate 2023 Highly Cited Researcher. She Ranked Top 8 Scientist and Top 1 female Scientist in the field of Medicine in China (2023 Best Global Scientists-Issued by Research.com).

She has 29 granted patents on GI cancer biomarkers and treatment targets. The licenced detection kits of stool biomarker miRNA92a for the early diagnosis of colorectal cancer and blood methylation DNA RNF180 for the diagnosis of gastric cancer have been approved by Chine FDA for clinical use. The stool bacteria detection kit for the early detection of colorectal cancer is used in Hong Kong and Asia.

« Go Back